Corporate reputation in the age of GLP-1

https://is1-ssl.mzstatic.com/image/thumb/Podcasts123/v4/fe/93/d6/fe93d645-9693-3a9c-ab86-593027013b0d/mza_2900503236915276937.png/600x600bb.jpg

Ipsos in the UK Podcast

Ipsos in the UK

107 episodes

2 days ago

Podcasts to showcase the latest innovations in market research and insights and interviews with key players in the world of UK politics and society.

Business News

News

RSS

All content for Ipsos in the UK Podcast is the property of Ipsos in the UK and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Podcasts to showcase the latest innovations in market research and insights and interviews with key players in the world of UK politics and society.

Business News

News

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/36484891/36484891-1749119794966-09ddad3788876.jpg

Corporate reputation in the age of GLP-1

Ipsos in the UK Podcast

35 minutes 33 seconds

6 months ago

Corporate reputation in the age of GLP-1

Listen to Thomas Fife-Schaw and Nick Gabery Adams, former VP of Corporate Brand at Novo Nordisk, discuss how GLP-1 medications like Ozempic and Wegovy are changing the pharmaceutical landscape. From reshaping corporate reputation, to boosting investor confidence, discover how these drugs are rewriting the rules for pharma brands.